Search Tag: rare disease

2025 27 May

RHEACELL and AOP Health have formed a new strategic partnership to deliver breakthrough therapies for the "butterfly children's" disease and chronic venous wounds. This partnership aims to provide patients with high unmet medical needs access to innovative cell therapies.   RHEACELL, a German biotech company specialised in the development of...Read more

2022 21 Apr

The  Axiom REACH Foundation  announced the appointment of its board of trustees, adding accomplished oncology and rare disease executives. The board will comprise of  Robert LaCaze ,  Biren Amin , and  Ambaw Bellete , and  Hafiz Sikder , founder and Executive Director. Robert LaCaze  will serve as co-director of the REACH board, bringing a wealth...Read more